What’s Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) Upside After This Short Interest Decrease?

October 13, 2017 - By Vivian Currie

 What's Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) Upside After This Short Interest Decrease?

The stock of Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) registered a decrease of 2.63% in short interest. APHB’s total short interest was 974,700 shares in October as published by FINRA. Its down 2.63% from 1.00 million shares, reported previously. With 104,400 shares average volume, it will take short sellers 9 days to cover their APHB’s short positions.

About 232,974 shares traded. Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) has declined 94.86% since October 13, 2016 and is downtrending. It has underperformed by 111.56% the S&P500.

AmpliPhi Biosciences Corporation is a biotechnology company. The company has market cap of $10.06 million. The Firm is focused on the discovery, development and commercialization of phage therapeutics. It currently has negative earnings. The Firm is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

More notable recent Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) news were published by: Businesswire.com which released: “AmpliPhi Biosciences Announces Closing of Public Offering” on May 10, 2017, also Reuters.com with their article: “BRIEF-Ampliphi Biosciences announces first intravenous treatment of a patient …” published on September 11, 2017, Businesswire.com published: “AmpliPhi Biosciences to Participate in Two Upcoming Conferences” on October 11, 2017. More interesting news about Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) were released by: Seekingalpha.com and their article: “AmpliPhi Biosciences Sweetens Follow-On Offering Terms” published on November 13, 2016 as well as Seekingalpha.com‘s news article titled: “AmpliPhi Biosciences Is Making Progress But A Catalyst Is Lacking” with publication date: October 31, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.